309 related articles for article (PubMed ID: 19028291)
1. Radiation dose is predictive of biochemical failure, local failure, and distant metastases. In regard to Kupelian et Al. (Int J Radiat Oncol Biol Phys 2008;71:16-22).
Kelly P
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1621-2; author reply 1622. PubMed ID: 19028291
[No Abstract] [Full Text] [Related]
2. Comment on dose escalation and biochemical failure in prostate cancer: in regard to Kuban et al. (Int J Radiat Oncol Biol Phys 2008;70:67-74).
Schulz RJ; Kagan AR
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1288; author reply 1288-9. PubMed ID: 18572089
[No Abstract] [Full Text] [Related]
3. Commentary on dose escalation and biochemical failure in prostate cancer: in regard to Eade et al. (Int. J. Radiat. Oncol. Biol. Phys. 2007;68:682-689).
Schulz RJ; Kagan AR
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):645; author reply 645-6. PubMed ID: 18207038
[No Abstract] [Full Text] [Related]
4. In regard to Kupelian et al.: Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seed/external beam radiotherapy for stage T1-T2 prostate cancer (Int J Radiat Oncol Biol Phys 2004;58:25-33).
Halperin RM
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):631-2; author reply 632. PubMed ID: 15667989
[No Abstract] [Full Text] [Related]
5. PSA failure and the risk of death in prostate cancer patients treated with radiotherapy: in regard to Kwan et al. (Int J Radiat Oncol Biol Phys 2004;60:1040-1046).
Williams S
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1253-4; author reply 1254. PubMed ID: 15990030
[No Abstract] [Full Text] [Related]
6. Intraoperative radiation therapy after radical prostatectomy: in regard to Saracino et Al. (Int j radiat oncol biol phys, in press).
Jereczek-Fossa BA; Orecchia R
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):305-6; author reply 306. PubMed ID: 18722291
[No Abstract] [Full Text] [Related]
7. CTV margins in prostate cancer irradiation. In regard to Teh et al.: IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease (Int J Radiat Oncol Biol Phys 2003;56:184-191).
Macias V
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):320-1; author reply 321-2. PubMed ID: 15093933
[No Abstract] [Full Text] [Related]
8. The need and prospect of individualized external beam radiotherapy dose escalation beyond 80 gy to treat prostate cancer: in regard to Eade et al. (Int J. Radiat. Oncol. Biol. Phys. 2007;68:682-689).
Cheung MR
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):645; author reply 645-6. PubMed ID: 18207039
[No Abstract] [Full Text] [Related]
9. In regard to Fiorino et al.: Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:953-962).
Bauman G; Rodrigues G
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):912-4; author reply 914-5. PubMed ID: 15183497
[No Abstract] [Full Text] [Related]
10. Post hoc, ergo propter hoc. In regard to Fietkau et al. (Int J Radiat Oncol Biol Phys 2007;67:1008-1019).
Widder J
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1581; author reply 1580-1. PubMed ID: 17674989
[No Abstract] [Full Text] [Related]
11. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy: in regard to Parks et al. (Int J Radiat Oncol Biol Phys 2008;72:1620-1621).
Tomé WA
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1286. PubMed ID: 19251106
[No Abstract] [Full Text] [Related]
12. Radiation-induced sequelae measured by means of lymphocyte apoptosis: importance of certain single nucleotide polymorphisms: in regard to Schnarr et al. (Int J Radiat Oncol Biol Phys 2009).
Azria D; Ozsahin M; Rosenstein B
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1275; author reply 1275-6. PubMed ID: 19857791
[No Abstract] [Full Text] [Related]
13. Radiation fields of neoadjuvant concurrent chemoradiotherapy for rectal cancer: in regard to Yu et al. (Int J Radiat Oncol Biol Phys 2008;71:1175-1180).
Chien CR; Chen SW; Chen WT
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):639; author reply 639-40. PubMed ID: 19147033
[No Abstract] [Full Text] [Related]
14. In regard to Trofimov et al.: Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison (Int J Radiat Oncol Biol Phys 2007;69:444-453).
Albertini F; Lomax AJ; Hug EB
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1333-4; author reply 1334-5. PubMed ID: 17967323
[No Abstract] [Full Text] [Related]
15. In regards to Thames et al.: increasing external beam dose for T1-T2 prostate cancer: effect on risk groups. (Int J Radiat Oncol Biol Phys 2006;65:975-981).
Pickles T; Williams SG
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):318-9; author reply 319. PubMed ID: 17189080
[No Abstract] [Full Text] [Related]
16. Clinical target volume for rectal cancer: in regard to Roels et al. (Int J Radiat Oncol Biol Phys 2006;65:1129-1142).
Bujko K; Bujko M; Pietrzak L
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):313. PubMed ID: 17448884
[No Abstract] [Full Text] [Related]
17. Breast conservative surgery with close or positive margins: in regard to Guinot et Al. (Int J Radiat Oncol Biol Phys 2007;68:1381-1387).
Sanz J; de Dios NR; Arnalot PF; López MA
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):962-3; author reply 963. PubMed ID: 18262110
[No Abstract] [Full Text] [Related]
18. Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001).
Ost P; Fonteyne V; De Neve W; De Gersem W; De Wagter C; Vandecasteele K; Duprez F; De Meerleer G
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1286; author reply 1287. PubMed ID: 19251105
[No Abstract] [Full Text] [Related]
19. Adjuvant malignant mesothelioma radiotherapy: How many difficulties! In regard to: Allen et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma (Int J Radiat Oncol Biol Phys 2006;65:640-645) and Gupta et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma (Int J Radiat Oncol Biol Phys 2005;63:1045-1052).
Russi EG; Pergolizzi S; Lucio F; Ricardi U
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1273-4; author reply 1274. PubMed ID: 17145545
[No Abstract] [Full Text] [Related]
20. Lung V20 measurements: In regard to Seppenwoolde et al. (Int J Radiat Oncol Biol Phys 2003;55:724-735), and Tsujino et al. (Int J Radiat Oncol Biol Phys 2003;56:1208-1209).
Garces YI; Miller RC
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1636; author reply 1636-7. PubMed ID: 15050346
[No Abstract] [Full Text] [Related]
[Next] [New Search]
